https://revistas.uautonoma.cl/index.php/ejhr <p><strong>European Journal of Health Research</strong></p> <p>The European Journal of Health Research (EJHR), e-ISSN: 2445-0308, was created in 2015 by the Spanish Scientific Society for Research and Training in Health Sciences (<a href="https://formacionasunivep.com/revistas">ASUNIVEP</a>) and since its creation it has been oriented to disseminate research in health sciences, carried out in Latin America in close collaboration with the <a href="https://www.uautonoma.cl/">Universidad Autónoma de Chile</a>. As of 2021 the journal is edited in Santiago de Chile by the Universidad Autónoma de Chile, in this way the EJHR journal becomes the official organ of its Faculty of Health Sciences and of the Spanish Scientific Society for Research and Training in Health Sciences (ASUNIVEP). Your e-ISSN registration: 2445-0308 was transferred to the ISNN Chile agency (https://portal.issn.org/resource/ISSN/2445-0308#)</p> <p>The European Journal of Health Research (EJHR) is a peer-reviewed, serialized publication, continuous publication. The objective is the dissemination and publication of empirical - research and / or theoretical works in any field related to Health, in its broadest aspect, extending its coverage to professionals from other related disciplines. All manuscripts will be sent to members of the Editorial Committee and experts on the subject for their evaluation, which will be anonymous and in pairs.</p> <p>This Journal <strong>DOES NOT APPLY PUBLICATION CHARGES</strong> at any stage of the process.</p> en-US <p>The publication are distributed under the <a href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International</a> license (<a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a>). The rights of the works published in this journal are the property of the author and they are free to distribute and disseminate them, as long as the source is correctly cited.</p> ejhr@uautonoma.cl (Dr. Iván Suazo Galdames) editorjournals@uautonoma.cl (Lucy Andrea Rubilar Urra) Thu, 23 Jan 2025 00:00:00 +0000 OJS 3.3.0.10 http://blogs.law.harvard.edu/tech/rss 60 https://revistas.uautonoma.cl/index.php/ejhr/article/view/2870 <p>Cardiovascular disease is the main cause of morbidity and mortality in diabetic patients and elevated fibrinogen concentration has been described as an important risk factor. Objective: to determine the plasma concentration of fibrinogen and its association with glycated hemoglobin (HbA1c) levels in patients with DM2. Materials and methods: An observational, non-experimental, correlational, cross-sectional, cross-sectional research was conducted between November 2023 and August 2024. We selected 120 participants of both sexes diagnosed with DM2 who attended the Internal Medicine office of the Hospital Provincial General Docente Riobamba, Ecuador (90 patients with DM2 and 30 controls). Subjects with a diagnosis of DM2 were divided into three groups according to their HbA1c levels: group 1 (HbA 1c &lt;6.5 %), group 2 (≥ 6.5% &lt;10.0 %), and group 3 (HbA1c ≥ 10.0 %). Blood glucose levels, lipid profile, and plasma fibrinogen were evaluated. Results: Statistically significant differences were observed between subjects with DM2 and controls regarding age, BMI, serum glucose concentration, and triacylglycerides (p&lt;0.05). Patients with DM2 showed higher mean plasma levels of fibrinogen than controls (P&lt;0.001). A significant positive correlation was observed between fibrinogen and HbA1c (r=0.8380, P&lt;0.0001). Conclusion: The correlation observed between fibrinogen concentration and HbA1c levels in the subjects with DM2 evaluated in this investigation, together with the increase in triacylglyceride concentration, supports the value of these markers for the early prediction of the main complications observed in diabetes, such as vascular dysfunction, the development of atherosclerosis and consequent cardiovascular damage.</p> Pablo Aguirre-Villegas, Adriana Pedreáñez Copyright (c) 2025 Pablo Aguirre-Villegas, Adriana Pedreáñez 3 https://creativecommons.org/licenses/by/4.0 https://revistas.uautonoma.cl/index.php/ejhr/article/view/2870 Fri, 28 Mar 2025 00:00:00 +0000 https://revistas.uautonoma.cl/index.php/ejhr/article/view/2908 <p class="p2"><strong>Title</strong>: Aminas Biógenas como biomarcador diagnóstico en enfermedades inflamatorias intestinalis [Aminas Biógenas como biomarcador diagnóstico en enfermedades inflamatorias intestinales]</p> <p class="p2"><strong>Authors</strong>: Juan A. López-Ayala, María Virtudes López-Ayala, Pablo Navarro-Hernández, Manuel Sánchez-Fernández.</p> <p class="p2"><strong>Indexing information</strong>: European Journal of Health Research - 2015, Vol. 1, Nº 3 (Págs.79-94)</p> <p class="p2"><strong>DOI</strong>: https://doi.org/10.30552/ejhr.v1i3.7</p> Editorial Comitee EJHR Copyright (c) 2025 Editorial Comitee EJHR https://creativecommons.org/licenses/by/4.0 https://revistas.uautonoma.cl/index.php/ejhr/article/view/2908 Thu, 23 Jan 2025 00:00:00 +0000